While the Federal Reserve remained concerned about the slow pace of economic recovery, it took no action to jumpstart the economy. The markets closed mixed with the Dow rising 7 points to 10,761 while Nasdaq slipped 6 points to 2349.
On the upside
Morgan Stanley analyst David Lewis expects Edwards Lifesciences (NYSE: EW) to report positive trial results on Thursday for its Sapiens transcatheter heart valve.
The Environmental Protection Agency is expected to approve E15 fuel, a 15% mix of ethanol to 85% gasoline, for vehicles made from 2001 to the present lifting shares of BioFuel Energy (Nasdaq: BIOF).
QuickLogic (Nasdaq: QUIK) presented at the EE Times Executive Roundtable today in Boston.
On the downside
AMAG Pharmaceuticals (Nasdaq: AMAG) will meet with the Food and Drug Administration to discuss possible side effects from its treatment Feraheme for iron deficiency anemia in chronic kidney disease patients.
Bloomberg reported that iStar Financial (NYSE: SFI) is exploring a pre-packaged bankruptcy plan.
CommonWealth (NYSE: CWH) priced its offering of 7.5 million common shares at $26.75 per share.
In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by nearly 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks fell 5 points to 664.
